Drug
Rivaroxaban Oral Tablet
Rivaroxaban Oral Tablet is a pharmaceutical drug with 4 clinical trials. Currently 3 active trials ongoing.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Active Trials
3(75%)
Phase Distribution
Ph phase_4
4
100%
Phase Distribution
0
Early Stage
0
Mid Stage
4
Late Stage
Phase Distribution4 total trials
Phase 4Post-market surveillance
4(100.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
0.0%
0 of 1 finished
Non-Completion Rate
100.0%
1 ended early
Currently Active
3
trials recruiting
Total Trials
4
all time
Status Distribution
Active(3)
Terminated(1)
Detailed Status
Active, not recruiting2
Recruiting1
Withdrawn1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
3
Success Rate
N/A
Most Advanced
Phase 4
Trials by Phase
Phase 44 (100.0%)
Trials by Status
active_not_recruiting250%
recruiting125%
withdrawn125%
Recent Activity
3 active trials
Showing 4 of 4
recruitingphase_4
Long-term Anticoagulation With Oral Factor Xa Inhibitor Versus Vitamin K Antagonist After Mechanical Aortic Valve Replacement
NCT04258488
active_not_recruitingphase_4
The Danish Non-vitamin K Antagonist Oral Anticoagulation Study in Patients With Atrial Fibrillation
NCT03129490
active_not_recruitingphase_4
The Danish Non-vitamin K Antagonist Oral Anticoagulation Study in Patients With Venous Thromboembolism (DANNOAC-VTE)
NCT03129555
withdrawnphase_4
Absorption of Rivaroxaban in Patients With Cervical Spinal Cord Injury
NCT02970773
Clinical Trials (4)
Showing 4 of 4 trials
NCT04258488Phase 4
Long-term Anticoagulation With Oral Factor Xa Inhibitor Versus Vitamin K Antagonist After Mechanical Aortic Valve Replacement
NCT03129490Phase 4
The Danish Non-vitamin K Antagonist Oral Anticoagulation Study in Patients With Atrial Fibrillation
NCT03129555Phase 4
The Danish Non-vitamin K Antagonist Oral Anticoagulation Study in Patients With Venous Thromboembolism (DANNOAC-VTE)
NCT02970773Phase 4
Absorption of Rivaroxaban in Patients With Cervical Spinal Cord Injury
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4